GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (NAS:QNTM) » Definitions » Cyclically Adjusted PB Ratio

QNTM (Quantum BioPharma) Cyclically Adjusted PB Ratio : 0.12 (As of May. 29, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Cyclically Adjusted PB Ratio?

As of today (2025-05-29), Quantum BioPharma's current share price is $12.58. Quantum BioPharma's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 was $103.29. Quantum BioPharma's Cyclically Adjusted PB Ratio for today is 0.12.

The historical rank and industry rank for Quantum BioPharma's Cyclically Adjusted PB Ratio or its related term are showing as below:

QNTM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.11
Current: 0.11

During the past 10 years, Quantum BioPharma's highest Cyclically Adjusted PB Ratio was 0.11. The lowest was 0.00. And the median was 0.00.

QNTM's Cyclically Adjusted PB Ratio is ranked better than
95.42% of 677 companies
in the Drug Manufacturers industry
Industry Median: 1.85 vs QNTM: 0.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Quantum BioPharma's adjusted book value per share data of for the fiscal year that ended in Dec24 was $4.992. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $103.29 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Quantum BioPharma Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Quantum BioPharma's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma Cyclically Adjusted PB Ratio Chart

Quantum BioPharma Annual Data
Trend Aug15 Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.04

Quantum BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.04 -

Competitive Comparison of Quantum BioPharma's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Quantum BioPharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum BioPharma's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quantum BioPharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Quantum BioPharma's Cyclically Adjusted PB Ratio falls into.


;
;

Quantum BioPharma Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Quantum BioPharma's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.58/103.29
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum BioPharma's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Quantum BioPharma's adjusted Book Value per Share data for the fiscal year that ended in Dec24 was:

Adj_Book=Book Value per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=4.992/127.3637*127.3637
=4.992

Current CPI (Dec24) = 127.3637.

Quantum BioPharma Annual Data

Book Value per Share CPI Adj_Book
201508 -0.574 100.579 -0.727
201608 -0.535 101.686 -0.670
201708 -0.752 103.108 -0.929
201812 356.838 105.399 431.202
201912 297.352 107.769 351.416
202012 123.081 108.559 144.401
202112 87.027 113.774 97.422
202212 51.591 120.964 54.321
202312 21.843 125.072 22.243
202412 4.992 127.364 4.992

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Quantum BioPharma  (NAS:QNTM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Quantum BioPharma Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Quantum BioPharma's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum BioPharma Business Description

Traded in Other Exchanges
Address
55 University Avenue, Suite 1003, Toronto, ON, CAN, M5J 2H7
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.